Clinical Trials Browser

Phase 2 × Uveal Melanoma × Valproic Acid × Clear all

NCT02068586 2026-03-16

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Phase 2 Active not recruiting

Uveal Melanoma